Cita APA (7a ed.)
Vandebosch, A., Mogg, R., Goeyvaerts, N., Truyers, C., Greenwood, B., Watson-Jones, D., . . . Vangeneugden, T. (2016). Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges. Clinical Trials, 13(1), 57-66.
Cita Chicago Style (17a ed.)
Vandebosch, An, Robin Mogg, Nele Goeyvaerts, Carla Truyers, Brian Greenwood, Debby Watson-Jones, Guillermo Herrera-Taracena, Wim Parys, y Tony Vangeneugden. "Simulation-guided Phase 3 Trial Design to Evaluate Vaccine Effectiveness to Prevent Ebola Virus Disease Infection: Statistical Considerations, Design Rationale, and Challenges." Clinical Trials 13, no. 1 (2016): 57-66.
Cita MLA (9a ed.)
Vandebosch, An, et al. "Simulation-guided Phase 3 Trial Design to Evaluate Vaccine Effectiveness to Prevent Ebola Virus Disease Infection: Statistical Considerations, Design Rationale, and Challenges." Clinical Trials, vol. 13, no. 1, 2016, pp. 57-66.
Precaución: Estas citas no son 100% exactas.